Wednesday May 4, 2022. BY | Arbitration and Conciliation The Supreme Court bench comprising Justices M.R. Shah and B.V. Nagarathna held, in a recent judgment Arbitral Tribunal (“Tribunal”) cannot pass an interim order under Section 17 of the Arbitration and Conciliation Act, 1996 (the “Act”) for depositing an amount in the dispute, if the liability
... Continue Reading.Category: Supreme Court
SALARIES OF THOSE EMPLOYESS WHO WORKED DURING CIRP CONSTITUTE CIRP COSTS & PROVIDENT FUND, GRATUITY FUND TO BE KEPT OUT OF THE LIQUIDATION ESTATE
Thursday April 28, 2022. BY | Insolvency and Bankruptcy Code The Supreme Court bench comprising of Justices MR Shah and Aniruddha Bose in the recent Judgement held that: – the wages or salaries of only such workmen/employees, who worked during the Corporate Insolvency Resolution Process (“CIRP”), shall be included in the CIRP costs; and –
... Continue Reading.An Arbitral Award can be set aside only when it is vitiated by patent illegality: SUPREME COURT
Thursday April 14, 2022. BY | Blog The Supreme Court, in a recent judgement, delivered on 30th March 2022, noted that apart from the grounds mentioned in Section 34(2)(b) of the Arbitration and Conciliation Act, 2013 (the “Act”), an arbitral award can be set aside only when it is vitiated by patent illegality, and not
... Continue Reading.Clarifying or Confusing the Quandary of Identical Marks: Renaissance Hotel Holdings Inc. v. Vijaya Sai and Others
We’re pleased to bring you a guest post by Sangita Sharma, looking at the Supreme Court’s order in the trademark infringement case Renaissance Hotel Holdings Inc. v. Vijaya Sai and Others. Sangita is a 3rd Year student at Gujarat National Law University and has written for us earlier here. Clarifying or Confusing the Quandary of
... Continue Reading.PC Act – More Time Taken For Preliminary Enquiry Not A Ground To Quash Criminal Proceedings: SC
In a very significant observation, the Apex Court has as recently as on October 29, 2021 in a learned, laudable, landmark and latest judgment titled The State of Jammu and Kashmir vs Dr Saleem Ur Rehman in Criminal Appeal No. 1170 of 2021 in exercise of its criminal appellate jurisdiction observed without mincing any words
... Continue Reading.SpicyIP Weekly Review (September 27 – October 3)
Zolgensma and the Inadequacies of the Compulsory Licensing Regime Poster for Zolgensma In a guest post, Akhil wrote about Zolgensma, Novartis’ gene therapy medication prescribed for treatment of Spinal Muscular Atrophy (‘SMA’). Akhil discusses the compulsory licensing provisions in the TRIPS Agreement, as well as the objectives and principles relating to safeguarding public interest in
... Continue Reading.Default Sentences Cannot Be Directed To Run Concurrently: SC
It is good to learn that the Apex Court has most recently in a learned, laudable, landmark and latest judgment titled Dumya Alias Lakhan Alias Inamdar, Etc vs State of Maharashtra in Criminal Appeal Nos. 818-820 of 2021 in S.L.P. (CRL.) Nos.6044-6046 of 2021 (Arising out of Diary No(s).43190 of 2019) delivered just recently on August
... Continue Reading.Letter of Intent not a binding contract unless such an intention is evident from its terms
Monday August 9, 2021. BY IndiaLaw Research | Civil The Supreme Court in South Eastern Coalfields Ltd & Others vs. M/s S Kumar’s Associations AKM (JV)[1] ruled that a Letter of Intent (“LoI”) is not a binding contract unless such an intention is evident from its terms. The Supreme Court observed, “The judicial views before
... Continue Reading.SpicyIP Weekly Review (August 2 – 8)
Madras HC on the Right to be Forgotten: A Welcome Development? Forget-me-not (Myosotis arvensis). Hand drawn botanical vector illustration In Part I of a two-part guest post, Sriya Sridhar discussed a Madras High Court case where the petitioner sought his name to be redacted from a judgment in a case where he was ultimately acquitted
... Continue Reading.After Natco’s Withdrawal, Bajaj Healthcare files for Compulsory License to Manufacture Baricitinib
Eli Lilly’s Logo (image from here) A recent report by The Print revealed that Indian drugmaker Bajaj Healthcare (‘BH’) has applied to the Patent Office for a compulsory license to manufacture Eli Lilly’s Baricitinib. At the moment, the application itself or any response from Eli Lilly to its filing is unavailable, but the report provides
... Continue Reading.